deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT07194694

Dexmedetomidine vs Ketamine as Adjuvants to Bupivacaine in Transversus Abdominus Plane Block in Inguinal Hernioplasty (DEX\KET in TAP)

Dexmedetomidine vs Ketamine as Adjuvants to Bupivacaine in Transversus Abdominus Plane Block in Inguinal Hernioplasty: A Randomized Clincal Controlled Trial

Sponsor: Ain Shams University

Conditions Postoperative Pain Relief
Interventions Bupivacaine Dexmedetomidine & Bupivacaine. ketamine and bupivacaine injection
Updated 4 times since 2025 Last updated: Jan 20, 2026 Started: Oct 22, 2025 Primary completion: Jan 15, 2026 Completion: Jan 20, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Postoperative Pain Relief, this trial is completed. The trial is conducted by Ain Shams University and has accumulated 4 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2025 – ~Nov 2025 · 31 days · monthly snapshotNot Yet Recruiting~Nov 2025 – ~Jan 2026 · 2 months · monthly snapshotNot Yet Recruiting~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  2. Jan 2026 — Feb 2026 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  3. Nov 2025 — Jan 2026 [monthly]

    Not Yet Recruiting PHASE3

  4. Oct 2025 — Nov 2025 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ain Shams University
Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations